Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DISITAMAB VEDOTIN: Who Reports Side Effects? Age, Gender & Country Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Gender Distribution

78.3%
Female
21.7%
Male

Age Information

The average age of patients reporting adverse events with DISITAMAB VEDOTIN is 62.4 years.

Geographic Distribution

The majority of adverse event reports for DISITAMAB VEDOTIN originate from CN.

Report Summary & Outcomes

56
Total Reports
56
As Primary/Secondary Suspect
2
Deaths Reported
33
Hospitalizations
5
Life-Threatening
2
Disabilities

Reporting Timeline

First adverse event report: 20190622. Most recent report: 20250811. View full timeline →

More About DISITAMAB VEDOTIN

DISITAMAB VEDOTIN Full Profile Reports by Year Drug Interactions